ReviewBreathe (Sheffield, England)2025

From basic scientific research to the development of new drugs for pulmonary arterial hypertension: insights from activin-targeting agents.

Christophe GuignabertPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.